Women and men are known to have different vulnerabilities to psychiatric and other illnesses. There are a variety of reasons, including biological differences between the sexes and a vast number of…
Read More
On August 4th, the U.S. Food and Drug Administration (FDA) approved zuranolone, the first oral medication designed to treat postpartum depression (PPD) in adults. The drug, which is rapid-acting, was…
Read More
